Abstract: Journal of Community Hospital Internal Medicine Perspectives Volume 12 Issue 6 Article 5 2022 Evaluation of Glycemic Control and Predictors of Severe Illness and Death in Patients With Diabetes Hospitalized With COVID-19 Jovan Milosavljevic Department of Medicine, Sinai Hospital of Baltimore, Baltimore, jovmilosa@gmail.com Navya Reddy Perkit Department of Medicine, Sinai Hospital of Baltimore, Baltimore Sakshi Jhawar Department of Medicine, Sinai Hospital of Baltimore, Baltimore Melbin Thomas Department of Medicine, Sinai Hospital of Baltimore, Baltimore Justin Ling Department of Medicine, Sinai Hospital of Baltimore, Baltimore See next page for additional authors Follow this and additional works at: https://scholarlycommons.gbmc.org/jchimp Recommended Citation Milosavljevic, Jovan; Perkit, Navya Reddy; Jhawar, Sakshi; Thomas, Melbin; Ling, Justin; Amankwah, Samuel; and Thomas, Asha Mary (2022) "Evaluation of Glycemic Control and Predictors of Severe Illness and Death in Patients With Diabetes Hospitalized With COVID-19," Journal of Community Hospital Internal Medicine Perspectives: Vol. 12: Iss. 6, Article 5. DOI: 10.55729/2000-9666.1127 Available at: https://scholarlycommons.gbmc.org/jchimp/vol12/iss6/5 This Research Article is brought to you for free and open access by the Journal at GBMC Healthcare Scholarly Commons. It has been accepted for inclusion in Journal of Community Hospital Internal Medicine Perspectives by an authorized editor of GBMC Healthcare Scholarly Commons. For more information, please contact GBMCcommons@gbmc.org. Evaluation of Glycemic Control and Predictors of Severe Illness and Death in Patients With Diabetes Hospitalized With COVID-19 Authors Jovan Milosavljevic, Navya Reddy Perkit, Sakshi Jhawar, Melbin Thomas, Justin Ling, Samuel Amankwah, and Asha Mary Thomas This research article is available in Journal of Community Hospital Internal Medicine Perspectives: https://scholarlycommons.gbmc.org/jchimp/vol12/iss6/5 Jovan Milosavljevic a,*, Navya R. Perkit a, Sakshi Jhawar a, Melbin Thomas a, Justin Ling a, Samuel Amankwah a, Asha M. Thomas b a b Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA Division of Endocrinology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA Abstract Objectives: To identify risk factors for severe disease and death among patients with diabetes and coronavirus disease 2019 (COVID-19) infection. Methods: This retrospective cohort study conducted at three hospitals included 733 consecutive patients with DM admitted with confirmed COVID-19 (March 1 - December 31, 2020). Multivariable logistic regression was performed to identify predictors of severe disease and death. Results: The mean age was 67.4 ± 14.3 years, 46.9% were males and 61.5% were African American. Among all patients, 116 (15.8%) died in the hospital. A total of 317 (43.2%) patients developed severe disease, 183 (25%) were admitted to an ICU and 118 (16.1%) required invasive mechanical ventilation. Increasing BMI (OR, 1.13; 95% CI, 1.02e1.25), history of chronic lung disease (OR, 1.49; 95% CI, 1.05e2.10) and increasing time since the last HbA1c test (OR, 1.25; 95% CI, 1.05e1.49) were the preadmission factors associated with increased odds of severe disease. Preadmission use of metformin (OR, 0.67; 95% CI, 0.47e0.95) or GLP-1 agonists (OR, 0.49; 95% CI, 0.27e0.87) was associated with decreased odds of severe disease. Increasing age (OR, 1.21; 95% CI,..